Christoph Brackmann's most recent trade in NovoCure Ltd was a trade of 81,499 Stock Options (Right to buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 121,150 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |